Nasdaq: ETON
Eton Pharmaceuticals insiders
The officers, directors and 10% owners of Eton Pharmaceuticals, Inc. who hold the most stock, valued at the live ETON price.
$61.36
ETON today −$630K (−1.02%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their ETON stock
- $82.3M
- Market value
- $1.77B
- Held by ranked insiders
- 4.65%
Insiders by value of ETON holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Sean Brynjelsen | President & CEO | 961,194 | $59.0M | 3.33% | 2264th |
| 2 | James R. Gruber | Chief Financial Officer | 213,420 | $13.1M | 0.74% | 7168th |
| 3 | Norbert G. Riedel | Director | 167,145 | $10.3M | 0.58% | 6653rd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Eton Pharmaceuticals; see each profile for the filing.